WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Large Growth in Short Interest
by Doug Wharley · The Cerbat GemWuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling 140,652 shares, an increase of 626.2% from the March 15th total of 19,369 shares. Based on an average daily trading volume, of 176,486 shares, the days-to-cover ratio is currently 0.8 days.
WuXi Biologics (Cayman) Price Performance
Shares of WXXWY stock traded up $0.07 on Friday, reaching $9.17. 61,445 shares of the company’s stock were exchanged, compared to its average volume of 68,227. The company’s fifty day simple moving average is $9.37 and its 200 day simple moving average is $9.21. WuXi Biologics has a 52 week low of $4.95 and a 52 week high of $11.21.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.